These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
116 related articles for article (PubMed ID: 1461177)
1. The role of lipid peroxidation in McArdle's disease: applications for treatment of other myopathies. Russo PJ; Phillips JW; Seidler NW Med Hypotheses; 1992 Oct; 39(2):147-51. PubMed ID: 1461177 [TBL] [Abstract][Full Text] [Related]
2. Metabolism of branched-chain amino acids and ammonia during exercise: clues from McArdle's disease. Wagenmakers AJ; Coakley JH; Edwards RH Int J Sports Med; 1990 May; 11 Suppl 2():S101-13. PubMed ID: 2193889 [TBL] [Abstract][Full Text] [Related]
3. The pathophysiology of McArdle's disease: clues to regulation in exercise and fatigue. Lewis SF; Haller RG J Appl Physiol (1985); 1986 Aug; 61(2):391-401. PubMed ID: 3528113 [TBL] [Abstract][Full Text] [Related]
8. A multi-parametric protocol to study exercise intolerance in McArdle's disease. Ricci G; Bertolucci F; Logerfo A; Simoncini C; Papi R; Franzoni F; Dell'Osso G; Servadio A; Masoni MC; Siciliano G Acta Myol; 2015 Dec; 34(2-3):120-125. PubMed ID: 27199539 [TBL] [Abstract][Full Text] [Related]
9. Increased muscular beta-hydroxyacyl CoA dehydrogenase with McArdle's disease. Turk WR; Heller SL; Norris BJ; Nemeth PM Muscle Nerve; 1990 Jul; 13(7):607-12. PubMed ID: 2388659 [TBL] [Abstract][Full Text] [Related]
10. Tricarboxylic acid cycle intermediates during incremental exercise in healthy subjects and in patients with McArdle's disease. Sahlin K; Jorfeldt L; Henriksson KG; Lewis SF; Haller RG Clin Sci (Lond); 1995 Jun; 88(6):687-93. PubMed ID: 7634753 [TBL] [Abstract][Full Text] [Related]
11. Exercise intolerance in patients with McArdle's disease or mitochondrial myopathies. Chaussain M; Camus F; Defoligny C; Eymard B; Fardeau M Eur J Med; 1992 Dec; 1(8):457-63. PubMed ID: 1341204 [TBL] [Abstract][Full Text] [Related]
12. [McArdle's disease without typical symptoms]. Watanabe M; Matsubara E; Amari M; Okamoto K; Hirai S Rinsho Shinkeigaku; 1990 Nov; 30(11):1247-51. PubMed ID: 2085931 [TBL] [Abstract][Full Text] [Related]
13. Glucose infusion abolishes the excessive ATP degradation in working muscles of a patient with McArdle's disease. Mineo I; Kono N; Yamada Y; Hara N; Kiyokawa H; Hamaguchi T; Kawachi M; Yamasaki T; Nakajima H; Kuwajima M Muscle Nerve; 1990 Jul; 13(7):618-20. PubMed ID: 2388661 [TBL] [Abstract][Full Text] [Related]
14. MR imaging as a potential diagnostic test for metabolic myopathies: importance of variations in the T2 of muscle with exercise. Jehenson P; Leroy-Willig A; de Kerviler E; Duboc D; Syrota A AJR Am J Roentgenol; 1993 Aug; 161(2):347-51. PubMed ID: 8333376 [TBL] [Abstract][Full Text] [Related]
15. The second wind phenomenon in McArdle's disease. Braakhekke JP; de Bruin MI; Stegeman DF; Wevers RA; Binkhorst RA; Joosten EM Brain; 1986 Dec; 109 ( Pt 6)():1087-101. PubMed ID: 3466659 [TBL] [Abstract][Full Text] [Related]
16. Decreased insulin action in skeletal muscle from patients with McArdle's disease. Nielsen JN; Vissing J; Wojtaszewski JF; Haller RG; Begum N; Richter EA Am J Physiol Endocrinol Metab; 2002 Jun; 282(6):E1267-75. PubMed ID: 12006356 [TBL] [Abstract][Full Text] [Related]
17. [Glucose metabolism during muscular exercise in McArdle's disease]. Krzentowski G; Pallikarakis N; Pirnay F Acta Clin Belg; 1979; 34(3):151-7. PubMed ID: 292291 [No Abstract] [Full Text] [Related]
18. Exercise capacity in a 78 year old patient with McArdle's disease: it is never too late to start exercising. Perez M; Martin MA; Rubio JC; Maté-Muñoz JL; Gómez-Gallego F; Foster C; Andreu AL; Arenas J; Lucia A; Fleck SJ Br J Sports Med; 2006 Aug; 40(8):725-6; discussion 726. PubMed ID: 16864568 [TBL] [Abstract][Full Text] [Related]